Harvard Bioscience (NASDAQ:HBIO) Posts Quarterly Earnings Results, Misses Estimates By $0.03 EPS

Harvard Bioscience (NASDAQ:HBIO) released its earnings results on Wednesday. The medical instruments supplier reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.03), Zacks reports. Harvard Bioscience had a negative return on equity of 4.64% and a negative net margin of 14.57%.

Harvard Bioscience Price Performance

NASDAQ:HBIO traded down $0.06 during trading hours on Wednesday, hitting $0.71. The company’s stock had a trading volume of 338,964 shares, compared to its average volume of 276,293. The stock has a fifty day simple moving average of $1.51 and a 200-day simple moving average of $2.11. The company has a market capitalization of $30.75 million, a P/E ratio of -2.14 and a beta of 1.46. Harvard Bioscience has a twelve month low of $0.70 and a twelve month high of $4.70. The company has a debt-to-equity ratio of 0.52, a current ratio of 2.06 and a quick ratio of 0.91.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Harvard Bioscience stock. Bank of America Corp DE increased its position in Harvard Bioscience, Inc. (NASDAQ:HBIO) by 44.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 38,883 shares of the medical instruments supplier’s stock after buying an additional 11,948 shares during the quarter. Bank of America Corp DE owned 0.09% of Harvard Bioscience worth $82,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 80.87% of the company’s stock.

About Harvard Bioscience

Harvard Bioscience, Inc develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings.